-
1
-
-
0028762425
-
Care of patients with ascites
-
Runyon BA. Care of patients with ascites. N Engl J Med 1994; 330: 337-342.
-
(1994)
N Engl J Med
, vol.330
, pp. 337-342
-
-
Runyon, B.A.1
-
3
-
-
0023766008
-
Ascitic fluid analysis in malignancy-related ascites
-
Runyon BA, Hoefs JC and Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology 1988; 8: 1104-1109.
-
(1988)
Hepatology
, vol.8
, pp. 1104-1109
-
-
Runyon, B.A.1
Hoefs, J.C.2
Morgan, T.R.3
-
4
-
-
70350616220
-
Mana-gement of ascites due to gastrointestinal ma-lignancy (review)
-
Saif MW, Siddiqui IA and Sohail MA. Mana-gement of ascites due to gastrointestinal ma-lignancy (review). Ann Saudi Med 2009; 29: 369-377.
-
(2009)
Ann Saudi Med
, vol.29
, pp. 369-377
-
-
Saif, M.W.1
Siddiqui, I.A.2
Sohail, M.A.3
-
5
-
-
77950911606
-
Management of drainage for malignant ascites in gynaecological cancer (review)
-
Keen A, Fitzgerald D, Bryant A. Management of drainage for malignant ascites in gynaecological cancer (review). Cochrane Database Syst Rev 2010; 20: CD007794.
-
(2010)
Cochrane Database Syst Rev
, vol.20
, pp. CD007794
-
-
Keen, A.1
Fitzgerald, D.2
Bryant, A.3
-
7
-
-
78751628167
-
Clinical trials on CIK cells: Fi-rst report of the international registry on CIK cells (IRCC)
-
Hontscha C, Borck Y, Zhou H, Messmer D and Schmidt-Wolf IG. Clinical trials on CIK cells: fi-rst report of the international registry on CIK cells (IRCC). J Cancer Res Clin Oncol 2011; 137: 305-310.
-
(2011)
J Cancer Res Clin Oncol
, vol.137
, pp. 305-310
-
-
Hontscha, C.1
Borck, Y.2
Zhou, H.3
Messmer, D.4
Schmidt-Wolf, I.G.5
-
8
-
-
68049140780
-
Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{al-pha}2a therapy in metastatic renal cell carcinoma patients
-
Schwaab T, Schwarzer A, Wolf B, Crosby NA. Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{al-pha}2a therapy in metastatic renal cell carcinoma patients. Clin Cancer Res 2009; 15: 4986-4992.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 4986-4992
-
-
Schwaab, T.1
Schwarzer, A.2
Wolf, B.3
Crosby, N.A.4
-
9
-
-
0036197888
-
Immunology of the peritoneal cavity: Relevance for host-tumor relation
-
Melichar B and Freedman RS. Immunology of the peritoneal cavity: relevance for host-tumor relation. Int J Gynecol Cancer 2002; 12: 3-17.
-
(2002)
Int J Gynecol Cancer
, vol.12
, pp. 3-17
-
-
Melichar, B.1
Freedman, R.S.2
-
10
-
-
0025856106
-
Use of a SCID mouseihuman lymphoma model to evaluate cytokine-induced killer cells with potent antitumour cell activity
-
Schmidt-Wolf IG, Negrin RS, Kiem HP, Blume KG and Weissman IL. Use of a SCID mouseihuman lymphoma model to evaluate cytokine-induced killer cells with potent antitumour cell activity. J Exp Med 1991; 174: 139-149.
-
(1991)
J Exp Med
, vol.174
, pp. 139-149
-
-
Schmidt-Wolf, I.G.1
Negrin, R.S.2
Kiem, H.P.3
Blume, K.G.4
Weissman, I.L.5
-
11
-
-
0027860412
-
Phenotypic characterization and identification of effector cells involved in tumour cell recognition of cytokine-induced ki-ller cells
-
Schmidt-Wolf IG, Lefterova P, Mehta BA, Fer-nandez LP, Huhn D, Blume KG, Weissman IL and Negrin RS. Phenotypic characterization and identification of effector cells involved in tumour cell recognition of cytokine-induced ki-ller cells. Exp Hematol 1993; 21: 1673-1679.
-
(1993)
Exp Hematol
, vol.21
, pp. 1673-1679
-
-
Schmidt-Wolf, I.G.1
Lefterova, P.2
Mehta, B.A.3
Fer-Nandez, L.P.4
Huhn, D.5
Blume, K.G.6
Weissman, I.L.7
Negrin, R.S.8
-
12
-
-
0029913888
-
Sensitivity of multidrug-resistant tumour cell lines to immunologic effector cells
-
Schmidt-Wolf IG, Lefterova P, Johnston V, Sc-heffold C, Csipai M, Mehta BA, Tsuruo T, Huhn D and Negrin RS. Sensitivity of multidrug-resistant tumour cell lines to immunologic effector cells. Cell Immunol 1996; 169: 85-90.
-
(1996)
Cell Immunol
, vol.169
, pp. 85-90
-
-
Schmidt-Wolf, I.G.1
Lefterova, P.2
Johnston, V.3
Sc-Heffold, C.4
Csipai, M.5
Mehta, B.A.6
Tsuruo, T.7
Huhn, D.8
Negrin, R.S.9
-
13
-
-
0028103808
-
A novel population of expanded human CD3+ CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency
-
Lu PH and Negrin RS. A novel population of expanded human CD3+ CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol 1994; 153: 1687-1696.
-
(1994)
J Immunol
, vol.153
, pp. 1687-1696
-
-
Lu, P.H.1
Negrin, R.S.2
-
14
-
-
0028917966
-
Potential of autologous immunologic effector cells for bone marrow purging in patients with chronic myeloid leukemia
-
Scheffold C, Brandt K, Neubauer V, Lefterova P, Degen B, Schöntube M, Huhn D, Neubauer A and Schmidt-Wolf IG. Potential of autologous immunologic effector cells for bone marrow purging in patients with chronic myeloid leukemia. Bone Marrow Transplant 1995; 15: 33-39.
-
(1995)
Bone Marrow Transplant
, vol.15
, pp. 33-39
-
-
Scheffold, C.1
Brandt, K.2
Neubauer, V.3
Lefterova, P.4
Degen, B.5
Schöntube, M.6
Huhn, D.7
Neubauer, A.8
Schmidt-Wolf, I.G.9
-
15
-
-
0032211175
-
Expansion of Philadelphia ch-romosome-negative CD3+ CD56+ cytotoxic ce-lls from chronic myeloid leukemiapatients: In vitro and in vivo efficacy in severe combined immunodeficiency disease mice
-
Hoyle C, Bangs C, Mehta B, Chang P, Kamel O and Negrin RS. Expansion of Philadelphia ch-romosome-negative CD3+ CD56+ cytotoxic ce-lls from chronic myeloid leukemiapatients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice. Blood 1998; 92: 3318-3327.
-
(1998)
Blood
, vol.92
, pp. 3318-3327
-
-
Hoyle, C.1
Bangs, C.2
Mehta, B.3
Chang, P.4
Kamel, O.5
Negrin, R.S.6
-
16
-
-
0035201489
-
Inte-ractions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations
-
Marten A, Ziske C, Schöttker B, Renoth S, Wei-neck S, Buttgereit P, Schakowski F, von Rucker A, Sauerbruch T and Schmidt-Wolf IG. Inte-ractions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations. J Immunother 2001; 24: 502-510.
-
(2001)
J Immunother
, vol.24
, pp. 502-510
-
-
Marten, A.1
Ziske, C.2
Schöttker, B.3
Renoth, S.4
Wei-Neck, S.5
Buttgereit, P.6
Schakowski, F.7
Von Rucker, A.8
Sauerbruch, T.9
Schmidt-Wolf, I.G.10
-
17
-
-
0034990302
-
Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA 19-9
-
Ziske C, Marten A, Schottker B, Buttgereit P, Schakowski F, Gorschlüter M, von Rücker A, Scheffold C, Chao N, Sauerbruch T and Sch-midt-Wolf IG. Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA 19-9. Mol Ther 2001; 3: 54-60.
-
(2001)
Mol Ther
, vol.3
, pp. 54-60
-
-
Ziske, C.1
Marten, A.2
Schottker, B.3
Buttgereit, P.4
Schakowski, F.5
Gorschlüter, M.6
Von Rücker, A.7
Scheffold, C.8
Chao, N.9
Sauerbruch, T.10
Sch-Midt-Wolf, I.G.11
-
18
-
-
72449163153
-
Omental immune aggregates and tumor metastasis within the peritoneal cavity
-
Sorensen EW, Gerber SA, Sedlacek AL, Rybalko VY, Chan WM, Lord EM. Omental immune aggregates and tumor metastasis within the peritoneal cavity. Immunol Res 2009; 45: 185-194.
-
(2009)
Immunol Res
, vol.45
, pp. 185-194
-
-
Sorensen, E.W.1
Gerber, S.A.2
Sedlacek, A.L.3
Rybalko, V.Y.4
Chan, W.M.5
Lord, E.M.6
-
19
-
-
79961105556
-
Omental milky spots in screening gastric cancer stem cells
-
Cao L, Hu X, Zhang Y, Sun XT. Omental milky spots in screening gastric cancer stem cells. Neoplasma 2011; 58: 20-26.
-
(2011)
Neoplasma
, vol.58
, pp. 20-26
-
-
Cao, L.1
Hu, X.2
Zhang, Y.3
Sun, X.T.4
-
20
-
-
18844483161
-
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin-2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinomatosis
-
Freedman RS, Kudelka AP, Kavanagh JJ. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin-2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinomatosis. Clin Ca-ncer Res 2000; 6: 2268-2278.
-
(2000)
Clin Ca-ncer Res
, vol.6
, pp. 2268-2278
-
-
Freedman, R.S.1
Kudelka, A.P.2
Kavanagh, J.J.3
-
21
-
-
4644237613
-
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
-
Curiel TJ, Coukos G, Zou L. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-949.
-
(2004)
Nat Med
, vol.10
, pp. 942-949
-
-
Curiel, T.J.1
Coukos, G.2
Zou, L.3
-
22
-
-
34250159834
-
Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+ CD56+ cells with platinum resistance
-
Bamias A, Tsiatas ML, Kafantari E. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+ CD56+ cells with platinum resistance. Gynecol Oncol 2007; 106: 75-81.
-
(2007)
Gynecol Oncol
, vol.106
, pp. 75-81
-
-
Bamias, A.1
Tsiatas, M.L.2
Kafantari, E.3
-
23
-
-
0030610251
-
Differences in the recognition of tumor-specific CD8+ T cells derived from solid tumor, metastatic lymph nodes and ascites in patients with gastric cancer
-
Kono K, Ichihara F, Izuka H, Sekikawa T and Matsumoto Y. Differences in the recognition of tumor-specific CD8+ T cells derived from solid tumor, metastatic lymph nodes and ascites in patients with gastric cancer. Int J Cancer 1997; 71: 978-981.
-
(1997)
Int J Cancer
, vol.71
, pp. 978-981
-
-
Kono, K.1
Ichihara, F.2
Izuka, H.3
Sekikawa, T.4
Matsumoto, Y.5
-
24
-
-
0019969717
-
Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2
-
Eberlein TJ, Rosenstein M and Rosenberg SA. Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2. J Exp Med 1982; 156: 385-397.
-
(1982)
J Exp Med
, vol.156
, pp. 385-397
-
-
Eberlein, T.J.1
Rosenstein, M.2
Rosenberg, S.A.3
-
25
-
-
5144226237
-
Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes
-
Rosenberg SA and Dudley ME. Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes. Proc Natl Acad Sci U S A 2004; 101 Suppl 2: 14639-14645.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 14639-14645
-
-
Rosenberg, S.A.1
Dudley, M.E.2
-
26
-
-
20244366111
-
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
-
Dudley ME, Wunderlich JR, Yang JC. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J Clin Oncol 2005; 23: 2346-2357.
-
(2005)
J Clin Oncol
, vol.23
, pp. 2346-2357
-
-
Dudley, M.E.1
Wunderlich, J.R.2
Yang, J.C.3
-
27
-
-
84890452839
-
Adoptive cell therapy: Honing that killer instinct
-
Humphries C. Adoptive cell therapy: Honing that killer instinct. Nature 2013; 504: S13-5.
-
(2013)
Nature
, vol.504
, pp. S13-S15
-
-
Humphries, C.1
-
28
-
-
0028069489
-
Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy
-
Freedman RS, Tomasovic B, Templin S. Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy. J Im-munol Methods 1994; 197: 145-160.
-
(1994)
J Im-munol Methods
, vol.197
, pp. 145-160
-
-
Freedman, R.S.1
Tomasovic, B.2
Templin, S.3
-
29
-
-
0025076560
-
trial of intraperitoneal recombinant interleukin-2/lymphokineactivated killer cells in patients with ovarian cancer
-
Stewart JA, Belinson JL, Moore AL. Phase I trial of intraperitoneal recombinant interleukin-2/lymphokineactivated killer cells in patients with ovarian cancer. Cancer Res 1990; 50: 6302-6310.
-
(1990)
Cancer Res
, vol.50
, pp. 6302-6310
-
-
Stewart, J.A.1
Belinson, J.L.2
Moore, A.L.3
Phase, I.4
-
30
-
-
0024996777
-
Intrape-ritoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity
-
Steis RG, Urba WJ, VanderMolen LA. Intrape-ritoneal lymphokine-activated killer-cell and interleukin-2 therapy for malignancies limited to the peritoneal cavity. J Clin Oncol 1990; 8: 1618-1629.
-
(1990)
J Clin Oncol
, vol.8
, pp. 1618-1629
-
-
Steis, R.G.1
Urba, W.J.2
Vandermolen, L.A.3
-
31
-
-
0026579264
-
Adoptive immunotherapy with activated macrophages grown in vitro from blood monocytes in cancer patients: A pilot study
-
Lopez M, Fechtenbaum J, David B. Adoptive immunotherapy with activated macrophages grown in vitro from blood monocytes in cancer patients: a pilot study. J Immunother 1992; 11: 209-217.
-
(1992)
J Immunother
, vol.11
, pp. 209-217
-
-
Lopez, M.1
Fechtenbaum, J.2
David, B.3
-
32
-
-
33644530039
-
Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer
-
Mac Manus MP, Matthews JP, Worotniuk V and Ball DL. Unexpected long-term survival after low-dose palliative radiotherapy for non-small cell lung cancer. Cancer 2006; 106: 1110-1116.
-
(2006)
Cancer
, vol.106
, pp. 1110-1116
-
-
Mac Manus, M.P.1
Matthews, J.P.2
Worotniuk, V.3
Ball, D.L.4
-
34
-
-
0029997017
-
De-ndritic cells in antitumor immune response. I. Defective antigen presentation in tumor-bearing hosts
-
Gabrilovich DI, Ciernik IF and Carbone DP. De-ndritic cells in antitumor immune response. I. Defective antigen presentation in tumor-bearing hosts. Cell Immunol 1996; 170: 101-110.
-
(1996)
Cell Immunol
, vol.170
, pp. 101-110
-
-
Gabrilovich, D.I.1
Ciernik, I.F.2
Carbone, D.P.3
-
35
-
-
0029893672
-
Dendritic cells in antitumor responses. II. Dendritic cells grown from bone marrow precursor, but not mature DC form tumor-bearing mice, are effective antigen carriers in the therapy of established tumors
-
Gabrilovich DI, Nadaf S, Corak J, Berzofsky JA and Carbone DP. Dendritic cells in antitumor responses. II. Dendritic cells grown from bone marrow precursor, but not mature DC form tumor-bearing mice, are effective antigen carriers in the therapy of established tumors. Cell Immunol 1996; 170: 111-119.
-
(1996)
Cell Immunol
, vol.170
, pp. 111-119
-
-
Gabrilovich, D.I.1
Nadaf, S.2
Corak, J.3
Berzofsky, J.A.4
Carbone, D.P.5
-
36
-
-
33846937046
-
CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors
-
Gorbachev AV, Kobayashi H, Kudo D, Tanne-nbaum CS, Finke JH, Shu S. CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors. J Im-munol 2007; 178: 2278-2286.
-
(2007)
J Im-munol
, vol.178
, pp. 2278-2286
-
-
Gorbachev, A.V.1
Kobayashi, H.2
Kudo, D.3
Tanne-Nbaum, C.S.4
Finke, J.H.5
Shu, S.6
-
37
-
-
33748756028
-
TGF-be-ta: A mobile purveyor of immune privilege
-
Wahl SM, Wen J and Moutsopoulos N. TGF-be-ta: a mobile purveyor of immune privilege. Immunol 2006; 213: 213-227.
-
(2006)
Immunol
, vol.213
, pp. 213-227
-
-
Wahl, S.M.1
Wen, J.2
Moutsopoulos, N.3
-
38
-
-
33845678877
-
Role of transforming growth factor-beta in cancer progression
-
Galliher AJ, Neil JR and Schiemann WP. Role of transforming growth factor-beta in cancer progression. Future Oncol 2006; 2: 743-763.
-
(2006)
Future Oncol
, vol.2
, pp. 743-763
-
-
Galliher, A.J.1
Neil, J.R.2
Schiemann, W.P.3
-
39
-
-
0026927829
-
Presence of interleukin-10 (IL-10) in the ascites of patients with ovarian and other intraabdominal cancers
-
Gotlieb WH, Abrams JS, Watson JM, Velu TJ, Berek JS and Martinez-Maza O. Presence of interleukin-10 (IL-10) in the ascites of patients with ovarian and other intraabdominal cancers. Cytokine 1992; 4: 385-390.
-
(1992)
Cytokine
, vol.4
, pp. 385-390
-
-
Gotlieb, W.H.1
Abrams, J.S.2
Watson, J.M.3
Velu, T.J.4
Berek, J.S.5
Martinez-Maza, O.6
-
40
-
-
0035885327
-
Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages
-
Liss C, Fekete MJ, Hasina R, Lam CD and Lingen MW. Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages. Int J Cancer 2001; 93: 781-785.
-
(2001)
Int J Cancer
, vol.93
, pp. 781-785
-
-
Liss, C.1
Fekete, M.J.2
Hasina, R.3
Lam, C.D.4
Lingen, M.W.5
-
41
-
-
0033050656
-
Markedly elevated levels of vascular endothelial growth factor in malignant ascites
-
Zebrowski BK, Liu W, Ramirez K, Akagi Y, Mills GB and Ellis LM. Markedly elevated levels of vascular endothelial growth factor in malignant ascites. Ann Surg Oncol 1999; 6: 373-378.
-
(1999)
Ann Surg Oncol
, vol.6
, pp. 373-378
-
-
Zebrowski, B.K.1
Liu, W.2
Ramirez, K.3
Akagi, Y.4
Mills, G.B.5
Ellis, L.M.6
|